摘要:
Process for the treatment of painful syndromes, especially local and/or visceral, consisting in the parenteral or topical administration of a therapeutically effective quantity of the (-) tartrate of (+)-(R)-1-[(3,4,5-trimethoxy)benzyloxymethyl]-1-phenyl-N,N-dimethyl-n-propylamine.
摘要:
The present invention relates to propanamines of general formula (I) ##STR1## in which: R1 is a phenyl radical optionally mono-, di- or trisubstituted in an identical or different manner with halogen atoms, or lower alkyl, lower haloalkyl or lower alkoxy radicals;R2 is a lower alkyl radical,R3 and R4 are a hydrogen atom or a lower alkyl, lower alkenyl or lower cycloalkyalkyl radical,R5 is a 5-to 7-membered cycloalkyl radical or a phenyl radical, andW represents a heterocycle .dbd.C[Q--(CH.sub.2).sub.n --Q] in which Q is an oxygen or sulfur atom and n is 2 or 3,and their acid addition salts with pharmaceutically acceptable acids. The invention also relates to antidiarrheal pharmaceutical compositions comprising the claimed propanamines.
摘要翻译:本发明涉及通式(I)的丙胺,其中:R 1是任选地以与卤素原子相同或不同的方式单,二或三取代的苯基,或低级烷基低级卤代烷基 或低级烷氧基; R2是低级烷基,R3和R4是氢原子或低级烷基,低级烯基或低级环烷基,R5是5-至7-元环烷基或苯基,W表示杂环= C [ Q-(CH2)nQ]其中Q是氧或硫原子,n是2或3,以及它们与药学上可接受的酸的酸加成盐。 本发明还涉及包含所要求保护的丙胺的止泻药物组合物。
摘要:
A compound which is a propanamine of general formula (I) ##STR1## in which: R1 is a phenyl radical optionally mono-, di- or trisubstituted,or is a 5- or 6-membered monocyclic heteroaryl radical in which the single heteroatom is nitrogen, oxygen or sulfur,R2 is a lower alkyl radical,R3 and R4 are a hydrogen atom or a lower alkyl, lower alkenyl or lower cycloalkylalkyl radical,or, together with the nitrogen atom to which they are attached, form a saturated 5- to 6-membered heterocycle comprising only one heteroatom,R5 is a 5- to 7-membered cycloalkyl radical, a phenyl radical or a 5- or 6-membered monocyclic heteroaryl radical,and W representsa group .dbd.CH--QH,or a heterocycle .dbd.C[Q--(CH2)n--Q],or a group .dbd.C.dbd.Q, in which groupsQ is an oxygen or sulfur atom,n has the value 2 or 3,W being .dbd.C.dbd.Q only when R3 and R4 are not both hydrogen, and their additions salts with pharmaceutically acceptable acids.A pharmaceutical composition comprising a compound of general formula (I) with the above definitions for the treatment of diarrheal states.
摘要翻译:作为通式(I)的丙胺的化合物,其中:R 1是任选被一个,二或三取代的苯基,或是5或6元单环杂芳基,其中 单个杂原子是氮,氧或硫,R2是低级烷基,R3和R4是氢原子或低级烷基,低级烯基或低级环烷基烷基,或者与它们相连的氮原子一起形成 饱和的5至6元杂环,仅包含一个杂原子,R 5为5-至7-元环烷基,苯基或5-或6-元单环杂芳基,W表示基团= CH-QH, 或杂环= C [Q-(CH 2)nQ]或基团= C = Q,其中基团Q是氧或硫原子,n具有值2或3,W仅当R 3为 和R4不同时为氢,并且它们与药学上可接受的酸相加。 一种药物组合物,其包含具有上述定义用于治疗腹泻状态的通式(I)的化合物。
摘要:
Enantiomers of (S) configuration of formula (I) ##STR1## in which R is H or methyl, with antiallergic and in particular antihistaminic activity, useful as medicinal products.